CRIP2 and breast carcinoma: Based on the above-described FRAP data, we hypothesized that the nuclear abundance and associated gene-regulatory activity of CRP2 in breast cancer cells are modulated by the actin polymerization state, i.e., the relative amounts of G- and F-actin.